|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: [email protected]. Type 508 Accommodation and the title of the report in the subject line of e-mail. Update: Influenza Activity -- United StatesFor the week ending February 16, 1985, 11 states (Florida, Hawaii, Nebraska, New Hampshire, New Mexico, Oklahoma, Pennsylvania, South Carolina, South Dakota, Texas, and Virginia) and the District of Columbia reported widespread outbreaks of influenza-like illness, and 17 states reported regional outbreaks. Trends of influenza activity are represented in Figure 1. Family physicians who report weekly to CDC noted an average of 9.7 cases of influenza-like illness for the reporting week ending February 6, compared with the average of 6.6 cases at the beginning of January. Of total deaths reported from 121 U.S. cities, the percentage associated with pneumonia and influenza (P&I) was 6.8% for the week ending February 16 and 6.9% for the preceding week. This compares with recent seasons when the P&I percentage exceeded 6%: in 1981, the P&I percentage peaked at 6.9%, and in 1976, at 7.7%. On both occasions, many outbreaks of influenza associated with type A(H3N2) strains were in progress. The total number of type A(H3N2) virus isolates reported to CDC from the network of WHO Collaborating Laboratories in the United States has increased sharply for the reporting weeks ending January 26 and February 2. Including recent reports from Maine and Vermont, influenza type A(H3N2) isolates have so far been reported from 44 states. Type B isolates have accounted for only nine of the 707 isolates reported by the collaborating laboratories. Reported by TK Lee, PhD, Bureau of Health, Maine Dept of Human Svcs; L Orciari, P Pelletier, MS, Vermont Dept of Health; participating physicians of the American Academy of Family Physicians; State and Territorial Epidemiologists; State Laboratory Directors; Other collaborating laboratories; Statistical Svcs Br, Div of Surveillance and Epidemiologic Studies, Epidemiology Program Office, Influenza Br, Div of Viral Diseases, Center for Infectious Diseases, CDC. Disclaimer All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to [email protected].Page converted: 08/05/98 |
|||||||||
This page last reviewed 5/2/01
|